The recall is definately not a positive, but I actually view it as the only negative of the last two days. Otherwise, the turnaround is on track and management is executing. Anyone interested in deep value won't do poorly if they have patience.
The other piece of negetive news is the earnings forcast for next quarter. They for said they expect about $0.20, analysts were expecting $0.26 next quarter. However they projected revenue higher. So, apparently they're going to go for higher revenue and trade their gross margins next quarter. It's interesting. They might be going for the jugular against the Icon product. Not sure though. I'm still digesting the news about the bowflex but it sounds serious. For the moment Astral seems to be a genius, but we'll just have to wait and see.
lol. I wish. I was surprised, had emotionally come to expect a jump upward.
Intellectually, I was only dodging the usual earnings-day volatility in this stock. At $17 it was not far off from my value guesstimate. I had no idea (lots of feelings but no numbers) whether it was gonna go up a few bucks or down a few bucks. I just didn't want to bet without a real 'edge'.